Answers are grounded in this paper and cite their sources.
Sir, Yearly influenza vaccination is currently recommended for patients with rheumatoid arthritis (RA) [1]. Case reports, however, suggest an association between influenza vaccination and the development or exacerbation of chronic autoimmune disorders such as RA, systemic lupus erythematosus (SLE) [2] and vasculitis [3–5]. We describe a case of systemic flare of pre‐existing RA concurrent with the first onset of cutaneous vasculitis following influenza vaccination. A 29‐yr‐old female smoker with a 12‐yr history of seropositive erosive RA presented with a polyarticular flare in addition to burning pain and bluish discoloration of the tips of several fingers and toes. Two weeks prior to the onset of symptoms she received Fluvax (CSL Limited, Australia) containing A/Johannesberg/82/96, A/Sydney/5/97 and B/Harbin/7/94 (B/Beijing/184/93‐like). She had been vaccinated on one previous occasion 2 yr earlier with Fluvax containing A/Texas/36/91, A/Johannesberg/33/94 and B/Beijing/184/93. For 12 months prior to presentation her arthritis was well controlled with weekly oral methotrexate (10 mg) and fortnightly intramuscular gold aurothioglucose (50 mg). Previous disease‐modifying agents included hydroxychloroquine, auranofin and d‐penicillamine; she had never used corticosteroids. Although her disease was widespread, no extra‐articular manifestations were previously apparent, including rheumatoid nodules and vasculitis.
No takes yet. Share an insight, caveat, or question.
Pupalan Iyngkaran (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: